Immune protective effect of human alpha-1-antitrypsin gene during β cell transplantation in diabetic mice

Immunologic Research

Volumn 62, Issue 1, 2015, Pages 71-80

  Yang, Lu ^a,b   Liao, Yu Ting ^a   Yang, Xiao Fei ^a,b   Reng, Li Wei ^a,b   Qi, Hui ^a   Li, Fu Rong ^a,c  

^a JINAN UNIVERSITY   (China)

^b MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^c Shenzhen Institute of Gerontology   (China)

Author keywords

Alpha 1 antitrypsin; Immune protective effect; Type 1 diabetes; cell transplantation

Indexed keywords

ALPHA 1 ANTITRYPSIN; CYTOKINE; MESSENGER RNA;

ANIMAL; BAGG ALBINO MOUSE; CELL DIFFERENTIATION; CELL LINE; CYTOLOGY; DENDRITIC CELL; DIABETES MELLITUS, EXPERIMENTAL; GENETICS; HUMAN; IMMUNOLOGY; KIDNEY; METABOLISM; MOUSE; PANCREAS ISLET BETA CELL; PATHOLOGY; REGULATORY T LYMPHOCYTE; TH17 CELL; TRANSPLANTATION;

ALPHA 1-ANTITRYPSIN; ANIMALS; CELL DIFFERENTIATION; CELL LINE; CYTOKINES; DENDRITIC CELLS; DIABETES MELLITUS, EXPERIMENTAL; HUMANS; INSULIN-SECRETING CELLS; KIDNEY; MICE; MICE, INBRED BALB C; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84939965262     PISSN: 0257277X     EISSN: 15590755     Source Type: Journal    
DOI: 10.1007/s12026-015-8636-2     Document Type: Article

References (40)

1. Aathira R, Jain V. Advances in management of type 1 diabetes mellitus. World J Diabetes. 2014;5(5):689–96. doi:10.4239/wjd.v5.i5.689.
2. Bruni A, Gala-Lopez B, Pepper AR, Abualhassan NS, Shapiro AJ. Islet cell transplantation for the treatment of type 1 diabetes: recent advances and future challenges. Diabetes Metab Syndr Obes. 2014;7:211–23. doi:10.2147/DMSO.S50789.
3. Abreu JR, Roep BO. Immune monitoring of islet and pancreas transplant recipients. Curr Diabetes Rep. 2013;13(5):704–12. doi:10.1007/s11892-013-0399-3.
4. Kanak MA, Takita M, Kunnathodi F, Lawrence MC, Levy MF, Naziruddin B. Inflammatory response in islet transplantation. Int J Endocrinol. 2014;2014:451035. doi:10.1155/2014/451035.
5. Azzi J, Geara AS, El-Sayegh S, Abdi R. Immunological aspects of pancreatic islet cell transplantation. Expert Rev Clin Immunol. 2010;6(1):111–24.
6. Loganathan G, Dawra RK, Pugazhenthi S, Wiseman AC, Sanders MA, Saluja AK, et al. Culture of impure human islet fractions in the presence of alpha-1 antitrypsin prevents insulin cleavage and improves islet recovery. Transplant Proc. 2010;42(6):2055–7. doi:10.1016/j.transproceed.2010.05.119.
7. Loganathan G, Dawra RK, Pugazhenthi S, Guo Z, Soltani SM, Wiseman A, et al. Insulin degradation by acinar cell proteases creates a dysfunctional environment for human islets before/after transplantation: benefits of alpha-1 antitrypsin treatment. Transplantation. 2011;92(11):1222–30. doi:10.1097/TP.0b013e318237585c.
8. Koulmanda M, Bhasin M, Fan Z, Hanidziar D, Goel N, Putheti P, et al. Alpha 1-antitrypsin reduces inflammation and enhances mouse pancreatic islet transplant survival. Proc Natl Acad Sci USA. 2012;109(38):15443–8. doi:10.1073/pnas.1018366109.
9. Lewis EC, Shapiro L, Bowers OJ, Dinarello CA. Alpha1-antitrypsin monotherapy prolongs islet allograft survival in mice. Proc Natl Acad Sci USA. 2005;102(34):12153–8. doi:10.1073/pnas.0505579102.
10. Zhang B, Lu Y, Campbell-Thompson M, Spencer T, Wasserfall C, Atkinson M, et al. Alpha1-antitrypsin protects beta-cells from apoptosis. Diabetes. 2007;56(5):1316–23. doi:10.2337/db06-1273.
11. Kalis M, Kumar R, Janciauskiene S, Salehi A, Cilio CM. Alpha 1-antitrypsin enhances insulin secretion and prevents cytokine-mediated apoptosis in pancreatic beta-cells. Islets. 2010;2(3):185–9. doi:10.4161/isl.2.3.11654.
12. Lewis EC, Mizrahi M, Toledano M, Defelice N, Wright JL, Churg A, et al. Alpha1-Antitrypsin monotherapy induces immune tolerance during islet allograft transplantation in mice. Proc Natl Acad Sci USA. 2008;105(42):16236–41. doi:10.1073/pnas.0807627105.
13. Wanner A, Arce AD, Pardee E. Novel therapeutic uses of alpha-1 antitrypsin: a window to the future. COPD. 2012;9(6):583–8. doi:10.3109/15412555.2012.717125.
14. Shahaf G, Moser H, Ozeri E, Mizrahi M, Abecassis A, Lewis EC. Alpha-1-antitrypsin gene delivery reduces inflammation, increases T-regulatory cell population size and prevents islet allograft rejection. Mol Med. 2011;17(9–10):1000–11. doi:10.2119/molmed.2011.00145.
15. Lu Y, Parker M, Pileggi A, Zhang B, Choi YK, Molano RD, et al. Human alpha 1-antitrypsin therapy induces fatal anaphylaxis in non-obese diabetic mice. Clin Exp Immunol. 2008;154(1):15–21. doi:10.1111/j.1365-2249.2008.03721.x.
16. Ma H, Lu Y, Li H, Campbell-Thompson M, Parker M, Wasserfall C, et al. Intradermal alpha1-antitrypsin therapy avoids fatal anaphylaxis, prevents type 1 diabetes and reverses hyperglycaemia in the NOD mouse model of the disease. Diabetologia. 2010;53(10):2198–204. doi:10.1007/s00125-010-1829-2.
17. Ye J, Liao YT, Jian YQ, Zhang XD, Wei P, Qi H, et al. Alpha-1-antitrypsin for the improvement of autoimmunity and allograft rejection in beta cell transplantation. Immunol Lett. 2013;150(1–2):61–8. doi:10.1016/j.imlet.2013.01.009.
18. Wang Y, Yan HJ, Zhou SY, Wang YS, Qi H, Deng CY, et al. The immunoregulation effect of alpha 1-antitrypsin prolong beta-cell survival after transplantation. PLoS One. 2014;9(4):e94548. doi:10.1371/journal.pone.0094548.
19. Li FR, Wang XG, Deng CY, Qi H, Ren LL, Zhou HX. Immune modulation of co-transplantation mesenchymal stem cells with islet on T and dendritic cells. Clin Exp Immunol. 2010;161(2):357–63. doi:10.1111/j.1365-2249.2010.04178.x.
20. Qi H, Liu JP, Deng CY, Zhou HX, Deng SP, Li FR. A role for anti-CD45RB monoclonal antibody treatment upon dendritic cells. Immunol Res. 2012;52(3):250–7. doi:10.1007/s12026-012-8336-0.
21. Deng CY, Qi H, Wang XG, Zhou HX, Deng SP, Li FR. Role of T and dendritic cells in mouse islet allografts treated with anti-CD45RB monoclonal antibodies. Transplant Proc. 2011;43(7):2721–7. doi:10.1016/j.transproceed.2011.05.049.
22. Fleixo-Lima G, Ventura H, Medini M, Bar L, Strauss P, Lewis EC. Mechanistic evidence in support of alpha1-antitrypsin as a therapeutic approach for type 1 diabetes. J Diabetes Sci Technol. 2014;8(6):1193–203. doi:10.1177/1932296814547096.
23. Lewis EC. Expanding the clinical indications for alpha(1)-antitrypsin therapy. Mol Med. 2012;18:957–70. doi:10.2119/molmed.2011.00196.
24. Burke SJ, Lu D, Sparer TE, Karlstad MD, Collier JJ. Transcription of the gene encoding TNF-alpha is increased by IL-1beta in rat and human islets and beta-cell lines. Mol Immunol. 2014;62(1):54–62. doi:10.1016/j.molimm.2014.05.019.
25. Wachlin G, Augstein P, Schroder D, Kuttler B, Kloting I, Heinke P, et al. IL-1beta, IFN-gamma and TNF-alpha increase vulnerability of pancreatic beta cells to autoimmune destruction. J Autoimmun. 2003;20(4):303–12.
26. Koulmanda M, Bhasin M, Awdeh Z, Qipo A, Fan Z, Hanidziar D, et al. The role of TNF-alpha in mice with type 1- and 2- diabetes. PLoS One. 2012;7(5):e33254. doi:10.1371/journal.pone.0033254.
27. Gottlieb PA, Alkanani AK, Michels AW, Lewis EC, Shapiro L, Dinarello CA, et al. Alpha1-Antitrypsin therapy downregulates toll-like receptor-induced IL-1beta responses in monocytes and myeloid dendritic cells and may improve islet function in recently diagnosed patients with type 1 diabetes. J Clin Endocrinol Metab. 2014;99(8):E1418–26. doi:10.1210/jc.2013-3864.
28. Abecassis A, Schuster R, Shahaf G, Ozeri E, Green R, Ochayon DE, et al. Alpha1-antitrypsin increases interleukin-1 receptor antagonist production during pancreatic islet graft transplantation. Cell Mol Immunol. 2014;11(4):377–86. doi:10.1038/cmi.2014.17.
29. Pott GB, Chan ED, Dinarello CA, Shapiro L. Alpha-1-antitrypsin is an endogenous inhibitor of proinflammatory cytokine production in whole blood. J Leukoc Biol. 2009;85(5):886–95. doi:10.1189/jlb.0208145.
30. Geginat J, Paroni M, Maglie S, Alfen JS, Kastirr I, Gruarin P, et al. Plasticity of human CD4 T cell subsets. Front Immunol. 2014;5:630. doi:10.3389/fimmu.2014.00630.
31. Suarez-Pinzon WL, Rabinovitch A. Approaches to type 1 diabetes prevention by intervention in cytokine immunoregulatory circuits. Int J Exp Diabetes Res. 2001;2(1):3–17.
32. Kikodze N, Pantsulaia I, Rekhviashvili K, Iobadze M, Dzhakhutashvili N, Pantsulaia N, et al. Cytokines and T regulatory cells in the pathogenesis of type 1 diabetes. Georgian Med News. 2013;222:29–35.
33. Sugimoto K, Itoh T, Takita M, Shimoda M, Chujo D, SoRelle JA, et al. Improving allogeneic islet transplantation by suppressing Th17 and enhancing Treg with histone deacetylase inhibitors. Transpl Int. 2014;27(4):408–15. doi:10.1111/tri.12265.
34. Bertin-Maghit S, Pang D, O’Sullivan B, Best S, Duggan E, Paul S, et al. Interleukin-1beta produced in response to islet autoantigen presentation differentiates T-helper 17 cells at the expense of regulatory T-cells: implications for the timing of tolerizing immunotherapy. Diabetes. 2011;60(1):248–57. doi:10.2337/db10-0104.
35. Subramanian S, Shahaf G, Ozeri E, Miller LM, Vandenbark AA, Lewis EC, et al. Sustained expression of circulating human alpha-1 antitrypsin reduces inflammation, increases CD4+ FoxP3+ Treg cell population and prevents signs of experimental autoimmune encephalomyelitis in mice. Metab Brain Dis. 2011;26(2):107–13. doi:10.1007/s11011-011-9239-9.
36. Lee CN, Lew AM, Wu L. The potential role of dendritic cells in the therapy of Type 1 diabetes. Immunotherapy. 2013;5(6):591–606. doi:10.2217/imt.13.48.
37. Thomas DC, Wong FS, Zaccone P, Green EA, Wallberg M. Protection of islet grafts through transforming growth factor-beta-induced tolerogenic dendritic cells. Diabetes. 2013;62(9):3132–42. doi:10.2337/db12-1740.
38. Chen L, Qiu M, He W, Huang A, Liu J. Functional study of immature dendritic cells co-transfected with IL-10 and TGF-beta 1 genes in vitro. Mol Biol Rep. 2012;39(6):6633–9. doi:10.1007/s11033-012-1468-4.
39. Ozeri E, Mizrahi M, Shahaf G, Lewis EC. Alpha-1 antitrypsin promotes semimature, IL-10-producing and readily migrating tolerogenic dendritic cells. J Immunol. 2012;189(1):146–53. doi:10.4049/jimmunol.1101340.
40. Guttman O, Yossef R, Freixo-Lima G, Rider P, Porgador A, Lewis EC. Alpha1-Antitrypsin modifies general NK cell interactions with dendritic cells and specific interactions with islet beta-cells in favor of protection from autoimmune diabetes. Immunology. 2014;. doi:10.1111/imm.12403.